3Q19 Earnings Announcement - AMC | Spero Therapeutics, Inc.

About
Pipeline
Antibiotic Resistance
Partners
Investors & Media
Careers
Contact

3Q19 Earnings Announcement - AMC

Overview
News Releases
Spero in the News
Events & Presentations
- Upcoming & Past Events
Stock Information
Corporate Governance
SEC Filings
IR Resources

3Q19 Earnings Announcement - AMC

Nov 4, 2019

Print Page

Print Page
RSS Feeds

RSS Feeds
Email Alerts

Email Alerts
Contact IR

Contact IR

About

Management Team
Board of Directors
Contact

Pipeline

Tebipenem HBr: Oral Gram-Negative Program
SPR720: Non-tuberculosis Mycobacterium
SPR206: Direct Acting IV Potentiator
Key Publications and Presentations

Antibiotic Resistance

Partners

Investors & Media

Overview
News Releases
Spero in the News
Events & Presentations
Stock Information
Corporate Governance
SEC Filings
IR Resources

Careers

©2022 Spero Therapeutics All Rights Reserved

Privacy Policy
Terms of Use